Crowdonomics
WatchlistPortfolio
Sano Chemicals

Reg CF · Common Stock · Jan 2025

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$199.8K / $5M max
4% of ceiling
Investors
74
$2.8K avg
Post-money valuation
$50.2M
pre-money + amount raised

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$295K
−$57K
FY2022
$0
−$380K
FY2023
RevenueNet income
Metric
FY2022 audited
FY2023 audited
Income statement
Revenue
$295,025
$0
Cost of goods sold
$250,759
$263,241
Gross margin
15%
—
Net income
-$56,975
-$380,283
Taxes paid
$0
$0
Balance sheet
Cash
$465,618
$560,124
Accounts receivable
$0
$0
Total assets
$766,195
$755,622
Short-term debt
$142,576
$0
Long-term debt
$45,513
$55,743
Total liabilities
$188,089
$55,743
Other
Headcount
—
9

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Apr 10, 2025
    • Deadline Apr 10, 2025 → Apr 30, 2025
    • Target $124K → $20K

    “Disclosed $743.5K in convertible notes and $190K in related party txns previously omitted from Form C; added FDA/QIDP disclaimers; updated Co-CEO time commitments, Min. Amount to $20K, adj. use of proceeds, and extended offering deadline.”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$50M
Post-money$50.2M
Price / share$5.43
Shares offered22,836

Perks

15% bonus shares · until Jan 23, 202515% bonus$1K+
20% bonus shares · until Jan 23, 202520% bonus$5K+
25% bonus shares · until Jan 23, 202525% bonus$10K+
30% bonus shares · until Jan 23, 202530% bonus$20K+
35% bonus shares · until Jan 23, 202535% bonus$50K+
12% bonus shares · Feb 13, 2025 – Feb 18, 202512% bonus$2.5K+
12% bonus shares · Mar 10, 2025 – Mar 15, 202512% bonus$2.5K+
— 5% bonus shares5% bonus$494+
— 10% bonus shares10% bonus$1K+
— 12% bonus shares12% bonus$5K+
— 15% bonus shares15% bonus$10K+
invitation to a virtual roundtable discussion with our lead researchers to discuss the future of biotechnology and healthcare solutions$25K+
— 20% bonus shares20% bonus$50K+

Offering details

Target$123,999
Max$4,999,998
Min investment—
OpenedJan 10, 2025
DeadlineApr 30, 2025
ClosedApr 30, 2025
Days active110

Links & provenance

Campaign pageSEC filing
Source: SEC EDGAR
0001665160-25-000042
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.